SlideShare a Scribd company logo
1
Hypertension During
Pregnancy
Chapter 25
CLASSIFICATION OF HYPERTENSION DURING
PREGNANCY
First four are the main categories of hypertension
During Pregnancy
1. Preeclampsia
2. Eclampsia
3. Gestational hypertension
4. Chronic hypertension
5. Preeclampsia superimposed on chronic
hypertension
See table 25-1 (classification of hypertension in
pregnancy), page 591
2
GESTATIONAL HYPERTENSION
 Blood pressure elevation (Systolic ≥ 140 mmHg
or diastolic ≥ 90 mmHg) after 20 weeks of
pregnancy, that is not accompanied by
proteinurea and returns to normal within 6
weeks postpartum.
 proteinuria is not present (negative or trace)
3
PREECLAMPSIA
Systolic blood pressure of 140
mmHg or more and diastolic
blood pressure of 90 mmHg or
more after 20 weeks of
pregnancy that is accompanied
by proteinurea more or equal
0.3 g in a 24 hour collection or
1+ or more in random urine
dipstick 4
ECLAMPSIA
Progression of
preeclampsia to generalized
seizures that cannot be
attributed to other causes
5
CHRONIC HYPERTENSION
Elevated blood pressure that
was known to exist before
pregnancy or develops before
20 weeks of pregnancy or
hypertension that is not
resolved during postpartum
period
6
PREECLAMPSIA SUPERIMPOSED ON CHRONIC
HYPERTENSION
 Development of new onset proteinurea more or equal
0.3 g in a 24 hour collection or 1+ or more in random
urine dipstick in a woman who has chronic
hypertension. In a woman who had proteinuria before
20 weeks of gestation,
 Preeclampsia should be suspected if woman has
sudden increase in proteinuria from baseline levels, a
sudden increase in blood pressure when it had been
previously well controlled.
 Development of thrombocytopenia (Platelets
<100,000/mm³) , or abnormal elevations of liver
enzymes (Aspartate aminotransferase (AST, (SGOT) )
or Alanine aminotransferase (ALT (SGPT))
7
RISK FACTORS
1.First pregnancy
2.Women older than 35 years.
3.Ethnicity (African- American)
4.Positive family history
5.Women who have chronic
hypertension or renal disease.
Cont. 8
RISK FACTORS CONT.
6. Overweight
7. Women with DM
8. Multifetal gestations
9. Presence of immunologic disorders.
10.Women married from fathers who has
previously fathered a pregnancy in
another woman that was complicated
with preeclampsia.
9
PATHOPHYSIOLOGY
Preeclampsia is a result of
generalized vasospasm
Vasoconstriction results in the
impeded blood flow and elevated
blood pressure. As a result,
circulation to all body organs,
including the kidneys, liver, brain
and placenta is decreased.
10
The most significant changes
 Decrease Renal Perfusion lead
to
 Decreased GFR
 Increased (BUN, Createnine, uric
acid)
 Proteinurea
 Generalized edema +4
 Increased blood viscosity (elevated
hematocrite)
 Water and sodium retention, rapid
weight gain 11
Decreased liver Perfusion
lead to
Impaired liver function
Hepatic edema and
subscapular hemorrhage
Elevated liver enzymes
Epigastric pain
12
VASOCONSTRICTION OF CEREBRAL VESSELS
LEAD TO
Cerebral hemorrhage
Headache
visual disturbances (blurred
vision and spot before eyes)
Hyperreflexia
13
DECREASED PLACENTAL PERFUSION
LEAD TO
Intra uterine growth restriction
Persistent fetal hypoxemia
Abruptio placenta and HELLP
syndrome(H:Hemolysis, EL: Elevated
liver Enzymes (AST and ALT), LP: Low
platelets counts <100,000/mm³)
 May results in DIC
Lung
Pulmonary edema ( symptoms
include dyspnea
14
Preventive measures:
1. Early and regular prenatal care
2. Monitor Weight gain
3. Monitor blood pressure
4. Monitoring of urinary protein
5. Anti oxidants therapy:
6. Recent researches assessed the benefit
of 1000mg of Vit C and 400 IU of Vit E
starting at 22 weeks.
7. Attempts of prevention in woman of
high risks. Cont.
15
ATTEMPTS OF PREVENTION IN WOMAN OF
HIGH RISKS INCLUDES
a) low dose aspirin
b) Calcium and
magnesium supplement
c) Fish oil supplements
16
MANIFESTATIONS:CLASSIC SIGNS:
HYPERTENSION & PROTEINUREA
17
 Systolic BP≥140 but
< 160 mm Hg
 Diastolic BP ≥ 90
but < 110 mm Hg
 Proteinuria ≥0.3g
but <2g in 24hr
collection
 1+ or higher on
random dipstick
sample
 Systolic BP ≥160
mm Hg
 Diastolic BP ≥110
mm Hg
 Proteinuria ≥5g in
24hr collection
 3+ or higher on
random dipstick
sample
Mild preeclampsia Severe preeclampsia
Additional Signs: (severe preeclampsia)
Retinal vasoconstriction
Hyperreflexia
Generalized edema +4
Impaired coagulation (decrease platelets
<100,000/mm³)
Lab test indicate liver and renal
dysfunction (creatinine >1.2mg/dL)
18
Symptoms: (severe preeclampsia)
 Continuous headache
 Drowsiness
 Mental confusion
 Convulsion (Eclampsia)
 Visual disturbances
 Epigastric pain
 Decreased urinary output < 500ml/
day or 30 ml/hr.(oligurea)
See table 25-3 (mild vs. severe
preeclampsia) page 594
19
Therapeutic Management:
Delivery is the only definitive
treatment but it may not be
practical if preeclampsia is mild
and the fetus is premature.
If the fetus less than 34 wks,
steroids to accelerate fetal lung
maturity will be given and delay
birth for 48 hrs.
20
If the maternal or fetal
condition deteriorates, the
woman will be delivered
regardless the fetal age or
administration of steroids.
Vaginal birth is preferred
because of the multisystem
impairments.
21
Home care for mild preeclampsia:
Home management is possible if
1.Preeclampsia is mild
2.The woman and the fetus in
stable condition
3.The woman can adhere to the
treatment plan
4.The woman make a follow up
visit every 3-4 days
22
CARE AT HOME
 Activity restriction; side lying
at least one and half hour a
day
 Fetal activity (kick count)
should report if no movement
noticed in a 4 hour period
 Weight daily each morning 23
 Urinanalysis for proteinurea
daily
 Diet, regular balance nutrition
without salt or fluid
restrictions
 Blood pressure checked 2 to 4
times daily
24
Inpatient management for
severe Preeclampsia:
Severe preeclampsia is diagnosed
if systolic Bp ≥ 160 or diastolic
≥110mmHg or multisystem
involvement
Delivery is necessary even if GW
less than 34
25
MANAGEMENT FOR SEVERE
PREECLAMPSIA
Bed rest on quiet environment
 Reduce external stimuli that precipitate convulsion
(noise, light)
Anticonvulsant medications (MgSo4)
Antihypertensive medications: If BP
≥ 160/110 Hydralazine is given.
26
S/S OF MAGNESIUM SULFATE TOXICITY
Respiratory rate < 12 per minute
Maternal pulse oximetre <95%
Hyporeflexia (absence DTR)
Sweating, flushing
Altered sensory (confusion and
drowsiness
Hypotension
Sudden decrease in FHR
Serum MgSo4 level >8 mg/dl
Urine output<30 ml /hour 27
Intrapartum Management:
 Monitor the mother to prevent
convulsions
 Keep woman on lateral position
 Vaginal births is usually the first choice
 Give oxytocin to stimulate birth
 Continuous fetal monitoring
 Pain control (narcotic or epidural)
 Mgso4 to prevent convulsion
28
Postpartum management:
Careful assessment of the mother’s
blood loss and signs of shock
Assessment of s/s of preeclampsia is
continuous for at least 48 hrs
Continue giving magnesium to
prevent seizures
29
Signs of recovering:
Urinary output 4-6 L/day
Decrease protein in urine
Return BP to normal within 2 weeks.
Gradual improvement in serum
laboratory values
30
Nursing care
1. Assessment:
 Weight daily
 Vital signs every 4 hour
 Ascultate the chest for moist breath sounds
(pulmonary edema)
 Assess edema every 4 hours
 Measure urine output hourly
 Check urine for protein every 4 hours
31
ASSESSMENT OF EDEMA
(+1) Minimal edema of lower
extremities
(+2) Marked edema of lower extremities
(+3) Edema of lower extremities, face,
hands and sacral area
(+4) Generalized massive edema that
include ascites (accumulation of fluid in
peritoneal cavity)
32
33
Fetal monitoring
Check brachial, radial and patellar
reflexes for hyperreflexia, or
hyporeflexia which indicate
magnesium excess
Ask woman about symptoms e.g.
headache, visual disturbances
epigastric pain, nausea vomiting and
increased edema.
34
Management of Eclampsia:
Maintain patent airway
Adequate oxygenation
Put the patient on lateral position to
prevent aspiration
After convulsion suction of food and
fluids
Administer anticonvulsant
Monitor fetal status
Blood specimen for type and Rh
Accurate assessment of urine output.
35
HELLP SYNDROME
H: Hemolysis
EL: Elevated liver Enzymes (AST and
ALT)
LP: Low platelets counts <100,000/mm³
The Prominent Symptoms:
Pain in the right upper quadrant, the
lower chest or epigastric area
Nausea, vomiting and severe edema
Treatment in intensive care unit
36

More Related Content

Similar to 9_hypertension_(1)_(3)[1].ppt

hypertension new.pptx
hypertension new.pptxhypertension new.pptx
hypertension new.pptx
VenoshaGunasekaran
 
hypertensive disorders.pdf
hypertensive  disorders.pdfhypertensive  disorders.pdf
hypertensive disorders.pdf
AbdoAboElsaad
 
Hypertension in pregnancy By Dr ahmad
Hypertension in pregnancy By Dr ahmadHypertension in pregnancy By Dr ahmad
Hypertension in pregnancy By Dr ahmad
Ayub Medical College
 
Hypertensive disorder during pregnancy.pptx
Hypertensive disorder during pregnancy.pptxHypertensive disorder during pregnancy.pptx
Hypertensive disorder during pregnancy.pptx
MesfinShifara
 
KIDNEY DISORDER IN PREGNANCY.pptx
KIDNEY DISORDER IN PREGNANCY.pptxKIDNEY DISORDER IN PREGNANCY.pptx
KIDNEY DISORDER IN PREGNANCY.pptx
Krishna Krish Krish
 
CIP.pptx
CIP.pptxCIP.pptx
CIP.pptx
Priyanka964777
 
Gestational hypertension
Gestational hypertensionGestational hypertension
Gestational hypertension
University of Florida
 
P R E G N A N C Y I N D U C E D H Y P E R T E N S I O N
P R E G N A N C Y  I N D U C E D  H Y P E R T E N S I O NP R E G N A N C Y  I N D U C E D  H Y P E R T E N S I O N
P R E G N A N C Y I N D U C E D H Y P E R T E N S I O N
Dr. Shaheer Haider
 
0000 PBM hypertensivedisordersinpregnancy 100515015806-phpapp 0002223344
0000 PBM  hypertensivedisordersinpregnancy 100515015806-phpapp 00022233440000 PBM  hypertensivedisordersinpregnancy 100515015806-phpapp 0002223344
0000 PBM hypertensivedisordersinpregnancy 100515015806-phpapp 0002223344
Sweta Sheoran
 
Hypertension in pregnancy
Hypertension in pregnancyHypertension in pregnancy
Hypertension in pregnancy
Mini Sood
 
pre_and_eclampsia.ppt
pre_and_eclampsia.pptpre_and_eclampsia.ppt
pre_and_eclampsia.ppt
Ogunsina1
 
HYPERTENSIVE DISORDER IN PREGNANCY.pptx
HYPERTENSIVE DISORDER IN PREGNANCY.pptxHYPERTENSIVE DISORDER IN PREGNANCY.pptx
HYPERTENSIVE DISORDER IN PREGNANCY.pptx
HannatAboud
 
htninpregnancy-130120114747-phpapp01.pdf
htninpregnancy-130120114747-phpapp01.pdfhtninpregnancy-130120114747-phpapp01.pdf
htninpregnancy-130120114747-phpapp01.pdf
SavitaHanamsagar
 
Htninpregnancy 130120114747-phpapp01
Htninpregnancy 130120114747-phpapp01Htninpregnancy 130120114747-phpapp01
Htninpregnancy 130120114747-phpapp01
Krupa Meet Patel
 
HYPERTENSIVE DISORDERS.pptx
HYPERTENSIVE DISORDERS.pptxHYPERTENSIVE DISORDERS.pptx
HYPERTENSIVE DISORDERS.pptx
GetanehLiknaw
 
Pregnancy-Complications-10-08-07.ppt
Pregnancy-Complications-10-08-07.pptPregnancy-Complications-10-08-07.ppt
Pregnancy-Complications-10-08-07.ppt
Shama
 
Obstetric HYPERTENSIVE diagnosis and treatment.pdf
Obstetric HYPERTENSIVE diagnosis and treatment.pdfObstetric HYPERTENSIVE diagnosis and treatment.pdf
Obstetric HYPERTENSIVE diagnosis and treatment.pdf
MaxamuudxasanMaxamed
 
04_Modern problems of pregnancy induced hypertension-2019.pptx
04_Modern problems of pregnancy induced hypertension-2019.pptx04_Modern problems of pregnancy induced hypertension-2019.pptx
04_Modern problems of pregnancy induced hypertension-2019.pptx
Ugo161BB
 
Group6-Case-Presentation.pptx
Group6-Case-Presentation.pptxGroup6-Case-Presentation.pptx
Group6-Case-Presentation.pptx
ReneroseTorres
 
Jeff Rundio, DO- OB Board Review 2014 - ARMC Emergency Medicine
Jeff Rundio, DO- OB Board Review 2014 - ARMC Emergency MedicineJeff Rundio, DO- OB Board Review 2014 - ARMC Emergency Medicine
Jeff Rundio, DO- OB Board Review 2014 - ARMC Emergency Medicine
Troy Pennington
 

Similar to 9_hypertension_(1)_(3)[1].ppt (20)

hypertension new.pptx
hypertension new.pptxhypertension new.pptx
hypertension new.pptx
 
hypertensive disorders.pdf
hypertensive  disorders.pdfhypertensive  disorders.pdf
hypertensive disorders.pdf
 
Hypertension in pregnancy By Dr ahmad
Hypertension in pregnancy By Dr ahmadHypertension in pregnancy By Dr ahmad
Hypertension in pregnancy By Dr ahmad
 
Hypertensive disorder during pregnancy.pptx
Hypertensive disorder during pregnancy.pptxHypertensive disorder during pregnancy.pptx
Hypertensive disorder during pregnancy.pptx
 
KIDNEY DISORDER IN PREGNANCY.pptx
KIDNEY DISORDER IN PREGNANCY.pptxKIDNEY DISORDER IN PREGNANCY.pptx
KIDNEY DISORDER IN PREGNANCY.pptx
 
CIP.pptx
CIP.pptxCIP.pptx
CIP.pptx
 
Gestational hypertension
Gestational hypertensionGestational hypertension
Gestational hypertension
 
P R E G N A N C Y I N D U C E D H Y P E R T E N S I O N
P R E G N A N C Y  I N D U C E D  H Y P E R T E N S I O NP R E G N A N C Y  I N D U C E D  H Y P E R T E N S I O N
P R E G N A N C Y I N D U C E D H Y P E R T E N S I O N
 
0000 PBM hypertensivedisordersinpregnancy 100515015806-phpapp 0002223344
0000 PBM  hypertensivedisordersinpregnancy 100515015806-phpapp 00022233440000 PBM  hypertensivedisordersinpregnancy 100515015806-phpapp 0002223344
0000 PBM hypertensivedisordersinpregnancy 100515015806-phpapp 0002223344
 
Hypertension in pregnancy
Hypertension in pregnancyHypertension in pregnancy
Hypertension in pregnancy
 
pre_and_eclampsia.ppt
pre_and_eclampsia.pptpre_and_eclampsia.ppt
pre_and_eclampsia.ppt
 
HYPERTENSIVE DISORDER IN PREGNANCY.pptx
HYPERTENSIVE DISORDER IN PREGNANCY.pptxHYPERTENSIVE DISORDER IN PREGNANCY.pptx
HYPERTENSIVE DISORDER IN PREGNANCY.pptx
 
htninpregnancy-130120114747-phpapp01.pdf
htninpregnancy-130120114747-phpapp01.pdfhtninpregnancy-130120114747-phpapp01.pdf
htninpregnancy-130120114747-phpapp01.pdf
 
Htninpregnancy 130120114747-phpapp01
Htninpregnancy 130120114747-phpapp01Htninpregnancy 130120114747-phpapp01
Htninpregnancy 130120114747-phpapp01
 
HYPERTENSIVE DISORDERS.pptx
HYPERTENSIVE DISORDERS.pptxHYPERTENSIVE DISORDERS.pptx
HYPERTENSIVE DISORDERS.pptx
 
Pregnancy-Complications-10-08-07.ppt
Pregnancy-Complications-10-08-07.pptPregnancy-Complications-10-08-07.ppt
Pregnancy-Complications-10-08-07.ppt
 
Obstetric HYPERTENSIVE diagnosis and treatment.pdf
Obstetric HYPERTENSIVE diagnosis and treatment.pdfObstetric HYPERTENSIVE diagnosis and treatment.pdf
Obstetric HYPERTENSIVE diagnosis and treatment.pdf
 
04_Modern problems of pregnancy induced hypertension-2019.pptx
04_Modern problems of pregnancy induced hypertension-2019.pptx04_Modern problems of pregnancy induced hypertension-2019.pptx
04_Modern problems of pregnancy induced hypertension-2019.pptx
 
Group6-Case-Presentation.pptx
Group6-Case-Presentation.pptxGroup6-Case-Presentation.pptx
Group6-Case-Presentation.pptx
 
Jeff Rundio, DO- OB Board Review 2014 - ARMC Emergency Medicine
Jeff Rundio, DO- OB Board Review 2014 - ARMC Emergency MedicineJeff Rundio, DO- OB Board Review 2014 - ARMC Emergency Medicine
Jeff Rundio, DO- OB Board Review 2014 - ARMC Emergency Medicine
 

Recently uploaded

10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
Traumasoft LLC
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
anaghabharat01
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
Pratik328635
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
Gokuldas Hospital
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
LEFLOT Jean-Louis
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Dr. Nikhilkumar Sakle
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
NX Healthcare
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 

Recently uploaded (20)

10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 

9_hypertension_(1)_(3)[1].ppt

  • 2. CLASSIFICATION OF HYPERTENSION DURING PREGNANCY First four are the main categories of hypertension During Pregnancy 1. Preeclampsia 2. Eclampsia 3. Gestational hypertension 4. Chronic hypertension 5. Preeclampsia superimposed on chronic hypertension See table 25-1 (classification of hypertension in pregnancy), page 591 2
  • 3. GESTATIONAL HYPERTENSION  Blood pressure elevation (Systolic ≥ 140 mmHg or diastolic ≥ 90 mmHg) after 20 weeks of pregnancy, that is not accompanied by proteinurea and returns to normal within 6 weeks postpartum.  proteinuria is not present (negative or trace) 3
  • 4. PREECLAMPSIA Systolic blood pressure of 140 mmHg or more and diastolic blood pressure of 90 mmHg or more after 20 weeks of pregnancy that is accompanied by proteinurea more or equal 0.3 g in a 24 hour collection or 1+ or more in random urine dipstick 4
  • 5. ECLAMPSIA Progression of preeclampsia to generalized seizures that cannot be attributed to other causes 5
  • 6. CHRONIC HYPERTENSION Elevated blood pressure that was known to exist before pregnancy or develops before 20 weeks of pregnancy or hypertension that is not resolved during postpartum period 6
  • 7. PREECLAMPSIA SUPERIMPOSED ON CHRONIC HYPERTENSION  Development of new onset proteinurea more or equal 0.3 g in a 24 hour collection or 1+ or more in random urine dipstick in a woman who has chronic hypertension. In a woman who had proteinuria before 20 weeks of gestation,  Preeclampsia should be suspected if woman has sudden increase in proteinuria from baseline levels, a sudden increase in blood pressure when it had been previously well controlled.  Development of thrombocytopenia (Platelets <100,000/mm³) , or abnormal elevations of liver enzymes (Aspartate aminotransferase (AST, (SGOT) ) or Alanine aminotransferase (ALT (SGPT)) 7
  • 8. RISK FACTORS 1.First pregnancy 2.Women older than 35 years. 3.Ethnicity (African- American) 4.Positive family history 5.Women who have chronic hypertension or renal disease. Cont. 8
  • 9. RISK FACTORS CONT. 6. Overweight 7. Women with DM 8. Multifetal gestations 9. Presence of immunologic disorders. 10.Women married from fathers who has previously fathered a pregnancy in another woman that was complicated with preeclampsia. 9
  • 10. PATHOPHYSIOLOGY Preeclampsia is a result of generalized vasospasm Vasoconstriction results in the impeded blood flow and elevated blood pressure. As a result, circulation to all body organs, including the kidneys, liver, brain and placenta is decreased. 10
  • 11. The most significant changes  Decrease Renal Perfusion lead to  Decreased GFR  Increased (BUN, Createnine, uric acid)  Proteinurea  Generalized edema +4  Increased blood viscosity (elevated hematocrite)  Water and sodium retention, rapid weight gain 11
  • 12. Decreased liver Perfusion lead to Impaired liver function Hepatic edema and subscapular hemorrhage Elevated liver enzymes Epigastric pain 12
  • 13. VASOCONSTRICTION OF CEREBRAL VESSELS LEAD TO Cerebral hemorrhage Headache visual disturbances (blurred vision and spot before eyes) Hyperreflexia 13
  • 14. DECREASED PLACENTAL PERFUSION LEAD TO Intra uterine growth restriction Persistent fetal hypoxemia Abruptio placenta and HELLP syndrome(H:Hemolysis, EL: Elevated liver Enzymes (AST and ALT), LP: Low platelets counts <100,000/mm³)  May results in DIC Lung Pulmonary edema ( symptoms include dyspnea 14
  • 15. Preventive measures: 1. Early and regular prenatal care 2. Monitor Weight gain 3. Monitor blood pressure 4. Monitoring of urinary protein 5. Anti oxidants therapy: 6. Recent researches assessed the benefit of 1000mg of Vit C and 400 IU of Vit E starting at 22 weeks. 7. Attempts of prevention in woman of high risks. Cont. 15
  • 16. ATTEMPTS OF PREVENTION IN WOMAN OF HIGH RISKS INCLUDES a) low dose aspirin b) Calcium and magnesium supplement c) Fish oil supplements 16
  • 17. MANIFESTATIONS:CLASSIC SIGNS: HYPERTENSION & PROTEINUREA 17  Systolic BP≥140 but < 160 mm Hg  Diastolic BP ≥ 90 but < 110 mm Hg  Proteinuria ≥0.3g but <2g in 24hr collection  1+ or higher on random dipstick sample  Systolic BP ≥160 mm Hg  Diastolic BP ≥110 mm Hg  Proteinuria ≥5g in 24hr collection  3+ or higher on random dipstick sample Mild preeclampsia Severe preeclampsia
  • 18. Additional Signs: (severe preeclampsia) Retinal vasoconstriction Hyperreflexia Generalized edema +4 Impaired coagulation (decrease platelets <100,000/mm³) Lab test indicate liver and renal dysfunction (creatinine >1.2mg/dL) 18
  • 19. Symptoms: (severe preeclampsia)  Continuous headache  Drowsiness  Mental confusion  Convulsion (Eclampsia)  Visual disturbances  Epigastric pain  Decreased urinary output < 500ml/ day or 30 ml/hr.(oligurea) See table 25-3 (mild vs. severe preeclampsia) page 594 19
  • 20. Therapeutic Management: Delivery is the only definitive treatment but it may not be practical if preeclampsia is mild and the fetus is premature. If the fetus less than 34 wks, steroids to accelerate fetal lung maturity will be given and delay birth for 48 hrs. 20
  • 21. If the maternal or fetal condition deteriorates, the woman will be delivered regardless the fetal age or administration of steroids. Vaginal birth is preferred because of the multisystem impairments. 21
  • 22. Home care for mild preeclampsia: Home management is possible if 1.Preeclampsia is mild 2.The woman and the fetus in stable condition 3.The woman can adhere to the treatment plan 4.The woman make a follow up visit every 3-4 days 22
  • 23. CARE AT HOME  Activity restriction; side lying at least one and half hour a day  Fetal activity (kick count) should report if no movement noticed in a 4 hour period  Weight daily each morning 23
  • 24.  Urinanalysis for proteinurea daily  Diet, regular balance nutrition without salt or fluid restrictions  Blood pressure checked 2 to 4 times daily 24
  • 25. Inpatient management for severe Preeclampsia: Severe preeclampsia is diagnosed if systolic Bp ≥ 160 or diastolic ≥110mmHg or multisystem involvement Delivery is necessary even if GW less than 34 25
  • 26. MANAGEMENT FOR SEVERE PREECLAMPSIA Bed rest on quiet environment  Reduce external stimuli that precipitate convulsion (noise, light) Anticonvulsant medications (MgSo4) Antihypertensive medications: If BP ≥ 160/110 Hydralazine is given. 26
  • 27. S/S OF MAGNESIUM SULFATE TOXICITY Respiratory rate < 12 per minute Maternal pulse oximetre <95% Hyporeflexia (absence DTR) Sweating, flushing Altered sensory (confusion and drowsiness Hypotension Sudden decrease in FHR Serum MgSo4 level >8 mg/dl Urine output<30 ml /hour 27
  • 28. Intrapartum Management:  Monitor the mother to prevent convulsions  Keep woman on lateral position  Vaginal births is usually the first choice  Give oxytocin to stimulate birth  Continuous fetal monitoring  Pain control (narcotic or epidural)  Mgso4 to prevent convulsion 28
  • 29. Postpartum management: Careful assessment of the mother’s blood loss and signs of shock Assessment of s/s of preeclampsia is continuous for at least 48 hrs Continue giving magnesium to prevent seizures 29
  • 30. Signs of recovering: Urinary output 4-6 L/day Decrease protein in urine Return BP to normal within 2 weeks. Gradual improvement in serum laboratory values 30
  • 31. Nursing care 1. Assessment:  Weight daily  Vital signs every 4 hour  Ascultate the chest for moist breath sounds (pulmonary edema)  Assess edema every 4 hours  Measure urine output hourly  Check urine for protein every 4 hours 31
  • 32. ASSESSMENT OF EDEMA (+1) Minimal edema of lower extremities (+2) Marked edema of lower extremities (+3) Edema of lower extremities, face, hands and sacral area (+4) Generalized massive edema that include ascites (accumulation of fluid in peritoneal cavity) 32
  • 33. 33
  • 34. Fetal monitoring Check brachial, radial and patellar reflexes for hyperreflexia, or hyporeflexia which indicate magnesium excess Ask woman about symptoms e.g. headache, visual disturbances epigastric pain, nausea vomiting and increased edema. 34
  • 35. Management of Eclampsia: Maintain patent airway Adequate oxygenation Put the patient on lateral position to prevent aspiration After convulsion suction of food and fluids Administer anticonvulsant Monitor fetal status Blood specimen for type and Rh Accurate assessment of urine output. 35
  • 36. HELLP SYNDROME H: Hemolysis EL: Elevated liver Enzymes (AST and ALT) LP: Low platelets counts <100,000/mm³ The Prominent Symptoms: Pain in the right upper quadrant, the lower chest or epigastric area Nausea, vomiting and severe edema Treatment in intensive care unit 36